Paolo Tarantino: Honored to serve as Ambassador for ESMOBreast24!
Paolo Tarantino shared a post by ESMO, on LinkedIn:
“Honored to join this outstanding group and serve as Ambassador for ESMOBreast24!”
Quoting ESMO‘s post:
“ESMOBreast24: ESMO is excited to announce the ESMO Ambassadors.
Stay up to date about the Scientific Advancements in Breast Cancer by following their updates. Take part in the conversation by sharing your insights on the latest science presented at ESMOBreast24.”
Source: Paolo Tarantino/LinkedIn and ESMO/LinkedIn
Dr. Paolo Tarantino, MD researcher, holds positions at both the European Institute of Oncology in Milan, Italy, and the Dana-Farber Cancer Institute in Boston, MA, Specializing in breast cancer. Currently, Dr. Tarantino is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan. His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer. With a robust publication record exceeding 50 papers on breast cancer, he is recognized as a leading expert in the field. Dr. Tarantino’s dedication and innovative approach contribute significantly to the advancement of breast cancer treatment and research.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023